Literature DB >> 197192

Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.

A B DeLeo, H Shiku, T Takahashi, M John, L J Old.   

Abstract

As background for a serological definition of the unique antigens of chemically induced sarcomas, we have typed a series of fibroblast and sarcoma cell lines of BALB/c and C57BL/6 origin by cytoxicity and absorption tests for murine leukemia virus (MuLV)-related cell surface antigens and known alloantigens. 7 of the 17 cultured lines expressed the range of cell surface antigens associated with MuLV (GIX, GCSA, gp70, p30), and this was invariably associated with MuLV production. In nonproducer lines of C57BL/6 (but not BALB/c) origin, a MuLV-gp70-like molecule was found on the surface of fibroblasts and sarcoma cells. The alloantigenic phenotype of these MuLV+ and MuLV- cell lines was H-2D+, H-2K+, Thy-1.2+ or -, PC.1+ or -, Lyt-1.2-, Lyt-2.2-, Ia.7-, and TL.2-. A unique antigen was defined on the BALB/c ascites sarcoma Meth A with antisera prepared in BALB/c or (BALB/c X C57BL/6)F1 mice. Tissue culture lines derived from this tumor were MuLV-, which facilitated serological study of the antigen. Absorption analysis indicated that the antigen was restricted to Meth A; it could not be detected in normal or fetal BALB/c tissue MuLV+ or MuLV- fibroblast lines, 12 syngeneic or allogeneic sarcomas, or normal lymphoid cells from 13 different inbred mouse strains.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 197192      PMCID: PMC2180799          DOI: 10.1084/jem.146.3.720

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  Tumour-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatibility antigens.

Authors:  G Invernizzi; G Parmiani
Journal:  Nature       Date:  1975-04-24       Impact factor: 49.962

2.  ANTIGENIC SPECIFICITY OF BENZO(A)PYRENE-INDUCED SARCOMAS.

Authors:  A GLOBERSON; M FELDMAN
Journal:  J Natl Cancer Inst       Date:  1964-06       Impact factor: 13.506

3.  ANTIGENIC PROPERTIES OF EXPERIMENTAL LEUKEMIAS. I. SEROLOGICAL STUDIES IN VITRO WITH SPONTANEOUS AND RADIATION-INDUCED LEUKEMIAS.

Authors:  L J OLD; E A BOYSE
Journal:  J Natl Cancer Inst       Date:  1963-10       Impact factor: 13.506

4.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

5.  Immunity to methylcholanthrene-induced sarcomas.

Authors:  R T PREHN; J M MAIN
Journal:  J Natl Cancer Inst       Date:  1957-06       Impact factor: 13.506

6.  Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.

Authors:  E J FOLEY
Journal:  Cancer Res       Date:  1953-12       Impact factor: 12.701

7.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

8.  Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test.

Authors:  H Shiku; M A Bean; L J Old; H F Oettgen
Journal:  J Natl Cancer Inst       Date:  1975-02       Impact factor: 13.506

9.  Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells.

Authors:  H Shiku; P Kisielow; M A Bean; T Takahashi; E A Boyse; H F Oettgen; L J Old
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

10.  THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES.

Authors:  A E REIF; J M ALLEN
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

View more
  75 in total

1.  Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding.

Authors:  F Janus; N Albrechtsen; U Knippschild; L Wiesmüller; F Grosse; W Deppert
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  A cell-surface epitope associated with liver-preferential metastasis detected by the new monoclonal antibody 3H4 in the murine tumor model ER 15-P.

Authors:  G G Wulf; G Edel; B Deneke; U Gottschalk; W Hiddemann; B Wörmann
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Stabilization of the p53 transformation-related protein in mouse fibrosarcoma cell lines: effects of protein sequence and intracellular environment.

Authors:  O Halevy; A Hall; M Oren
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

4.  A monoclonal antibody to Ly-6 gene product inhibits generation of functionally active T cells and recognizes single antigenic specificity whose expression is up-regulated in virus-transformed rat fibroblast.

Authors:  A Haque; M Chamekh; J Cornelis; A Capron; S Haque
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

5.  In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.

Authors:  Hiroyoshi Nishikawa; Eiichi Sato; Gabriel Briones; Li-Mei Chen; Mitsutoshi Matsuo; Yasuhiro Nagata; Gerd Ritter; Elke Jäger; Hideki Nomura; Shigeto Kondo; Isao Tawara; Takuma Kato; Hiroshi Shiku; Lloyd J Old; Jorge E Galán; Sacha Gnjatic
Journal:  J Clin Invest       Date:  2006-06-22       Impact factor: 14.808

6.  CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses.

Authors:  Hiroyoshi Nishikawa; Takuma Kato; Koji Tanida; Atsunori Hiasa; Isao Tawara; Hiroaki Ikeda; Yoshinori Ikarashi; Hiro Wakasugi; Mitchell Kronenberg; Toshinori Nakayama; Masaru Taniguchi; Kagemasa Kuribayashi; Lloyd J Old; Hiroshi Shiku
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

7.  Cell surface antigens: invaluable landmarks reflecting the nature of cells.

Authors:  Toshitada Takahashi; Hiroshi Shiku
Journal:  Cancer Immun       Date:  2012-05-01

8.  AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization.

Authors:  T E Carey; K O Lloyd; T Takahashi; L R Travassos; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

9.  High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice.

Authors:  N Hopkins; P Besmer; A B DeLeo; L W Law
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

10.  Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

Authors:  Lyse A Norian; Paulo C Rodriguez; Leigh A O'Mara; Jovanny Zabaleta; Augusto C Ochoa; Marina Cella; Paul M Allen
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.